Trial record 1 of 1 for:    NCT00805129
Previous Study | Return to List | Next Study

Everolimus (RAD001) in Metastatic Transitional Cell Carcinoma of the Urothelium

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Novartis Pharmaceuticals
Information provided by (Responsible Party):
Memorial Sloan-Kettering Cancer Center
ClinicalTrials.gov Identifier:
NCT00805129
First received: December 8, 2008
Last updated: July 24, 2013
Last verified: July 2013